Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
01/12/2012 | WO2012006473A1 Compounds and methods for inhibiting phosphate transport |
01/12/2012 | WO2012006419A2 Pro-neurogenic compounds |
01/12/2012 | WO2012006203A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors |
01/12/2012 | WO2012006202A1 Rho kinase inhibitors |
01/12/2012 | WO2012005363A1 Organic electroluminescent element |
01/12/2012 | WO2012005343A1 Substituted pyridine compound |
01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
01/12/2012 | WO2012005216A1 Pest control agent |
01/12/2012 | WO2012005172A1 Organic electroluminescent element |
01/12/2012 | WO2012004811A1 Process for the preparation of 5-substsituted indole derivative |
01/12/2012 | WO2012004743A1 Benzenesulfonamides useful as sodium channel inhibitors |
01/12/2012 | WO2012004722A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
01/12/2012 | WO2012004714A2 Chemical compounds |
01/12/2012 | WO2012004698A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
01/12/2012 | WO2012004397A1 Intermediates and process for preparing a thrombin specific inhibitor |
01/12/2012 | WO2012004396A2 Process of preparing a thrombin specific inhibitor |
01/12/2012 | WO2012004212A1 Heterocyclic antiviral compounds |
01/12/2012 | WO2012004208A1 Anthranilic acid diamide derivative as a pesticide |
01/12/2012 | WO2012004207A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
01/12/2012 | WO2012003912A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
01/12/2012 | WO2011123678A3 Substituted benzo-pyrido-triazolo-diazepine compounds |
01/12/2012 | WO2011103202A3 Androgen receptor modulators and uses thereof |
01/12/2012 | US20120010410 (2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof |
01/12/2012 | US20120010263 Acetylene derivatives having mglur 5 antagonistic activity |
01/12/2012 | US20120010250 Anthranilamide derivatives as pesticides |
01/12/2012 | US20120010249 Anthranilic diamide derivatives having cyclic side-chains |
01/12/2012 | US20120010244 Indole derivatives as ikk2 inhibitors |
01/12/2012 | US20120010242 Low dose pipamperone in treating mood disorders |
01/12/2012 | US20120010241 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof |
01/12/2012 | US20120010235 N-substituted pyrrolidines |
01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
01/12/2012 | US20120010214 3-(IMIDAZOLYL)-PYRAZOLO[3,4-b]PYRIDINES |
01/12/2012 | US20120010212 Methyl-pyrrolidine ether derivatives |
01/12/2012 | US20120010206 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
01/12/2012 | US20120010204 Phthalazinone Derivatives |
01/12/2012 | US20120010191 Pyridone and aza-pyridone compounds and methods of use |
01/12/2012 | US20120010190 1-hydroxyimino-3-phenyl-propanes |
01/12/2012 | US20120010185 New pyridone derivates with mch antagonistic activity and medicaments comprising these compounds |
01/12/2012 | US20120010184 Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor |
01/12/2012 | US20120010183 Chemical Compounds |
01/12/2012 | US20120010182 Chemical Compounds |
01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
01/12/2012 | US20120010172 Novel urea and thiourea derivatives |
01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
01/12/2012 | US20120009144 Heterocyclic antiviral compounds |
01/12/2012 | US20120009142 Methods for treating hepatitis c |
01/12/2012 | CA2805452A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
01/12/2012 | CA2804924A1 Substituted pyridine compound |
01/12/2012 | CA2804593A1 Biphenyloxybenzensulphonamide derivatives |
01/12/2012 | CA2804285A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
01/12/2012 | CA2804165A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
01/12/2012 | CA2803717A1 (3-methylpyrrolidin-3-yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
01/12/2012 | CA2803118A1 Sulfonamide derivatives as nav 1.7 inhibitors |
01/12/2012 | CA2801670A1 Heterocyclic antiviral compounds |
01/11/2012 | EP2404918A1 Pyridine derivative |
01/11/2012 | EP2404917A1 Tetrazoyl oxime derivative, salt thereof, and plant disease control agent |
01/11/2012 | EP2404905A1 New compounds |
01/11/2012 | EP2404902A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
01/11/2012 | EP2404901A1 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
01/11/2012 | EP2403852A1 3h-imidazo [4, 5 -c]pyridine- 6 -carboxamides as anti- inflammatory agents |
01/11/2012 | EP2403847A1 Triazine derivatives as kinase inhibitors |
01/11/2012 | EP2403846A1 Inhibitors of bruton's tyrosine kinase |
01/11/2012 | EP2403845A2 Improved process |
01/11/2012 | EP2403844A1 Heterocyclic antiviral compounds |
01/11/2012 | EP2403837A1 3-arylquinazolin-4-one compounds for combating invertebrate pests |
01/11/2012 | EP2403835A1 Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators |
01/11/2012 | EP2403834A1 Fungicidal pyrazoles |
01/11/2012 | EP2403833A1 8-substituted quinolines and related analogs as sirtuin modulators |
01/11/2012 | EP2403832A1 N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators |
01/11/2012 | EP2403499A2 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell |
01/11/2012 | EP2403338A1 Imidazole derivatives useful as modulators of faah and as faah imaging agents |
01/11/2012 | EP2173737B1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
01/11/2012 | EP2173735B1 Imidazole derivatives as ccr2 receptor antagonists |
01/11/2012 | EP2152690B1 Pyridyl piperidine orexin receptor antagonists |
01/11/2012 | EP2150534B1 Isoquinolinone derivatives as nk3 antagonists |
01/11/2012 | EP2057127B1 Hydantoin derivatives useful as antibacterial agents |
01/11/2012 | EP1802591B1 Quinazoline derivatives |
01/11/2012 | EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
01/11/2012 | CN102317284A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
01/11/2012 | CN102317282A Hetero ring derivative |
01/11/2012 | CN102317280A Oxyindole derivatives with motilin receptor agonistic activity |
01/11/2012 | CN102317279A Tetrazole substituted anthranilic acid amides as pesticides |
01/11/2012 | CN102317278A 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
01/11/2012 | CN102317277A C-met protein kinase inhibitors |
01/11/2012 | CN102317269A Novel amino azaheterocyclic carboxamides |
01/11/2012 | CN102317268A 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
01/11/2012 | CN102316900A Aniline derivative having anti-rna viral activity |
01/11/2012 | CN102311729A Electrochromic material, preparation method thereof, glare-proof rearview mirror for automobiles |
01/11/2012 | CN102311425A Anticoccidiosis compound and preparation method as well as application thereof |
01/11/2012 | CN102311424A Method for synthesizing chlorantraniliprole key intermediate |
01/11/2012 | CN102311399A Triazole alcohol antifungal compounds with nitrogen-containing side chains, preparation method thereof and application thereof |
01/11/2012 | CN102311398A Triazole compounds, preparation method thereof, and application thereof in preparing histone deacetylase I inhibitor |
01/11/2012 | CN102311387A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
01/11/2012 | CN101466671B Novel microbiocides |